PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Health

Aggressive cancer type linked to common chemical exposure in new study

NIH study links higher blood levels of two legacy PFAS chemicals to nearly double the rate of aggressive ER-negative breast cancer in women.

11sources
11articles
9velocity
+630%since first seen
5d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

Women with higher blood levels of two common per- and polyfluoroalkyl substances (PFAS) had significantly higher rates of estrogen receptor-negative (ER-negative) breast cancer, according to a National Institutes of Health study published in the Journal of Clinical Oncology. The research, led by NIH Stadtman Investigator Alexandra White, PhD, analyzed data from the Sister Study, which enrolled 50,884 women ages 35–74 in the U.S. and Puerto Rico from 2003 to 2009. None had breast cancer at enrollment, but each had a sister previously diagnosed with the disease. Researchers compared 1,609 women who developed breast cancer with a comparison sample of 2,269 women, oversampling ER-negative cases (324 ER-negative, 1,120 ER-positive) to improve statistical power. Seventeen PFAS were quantified in prediagnostic plasma using liquid chromatography-high-resolution mass spectrometry. Women in the group with the highest perfluorooctanoic acid (PFOA) levels had a 67% higher rate of ER-negative breast cancer than those in the lowest group. For perfluorooctanesulfonic acid (PFOS), the rate was 93% higher — nearly twice as high. These numbers describe relative differences between groups, not an individual woman's chance of getting breast cancer. No clear association was observed between the two chemicals and breast cancer risk overall. Meta-analyses including prior prospective studies showed consistent positive associations of PFOA and PFOS with ER-negative breast cancer. "Our findings, which we confirmed using a meta-analysis of prior research, indicate that certain legacy PFAS, including PFOA and PFOS, are associated with a higher risk of ER-negative breast cancer, a more aggressive tumor type with few known risk factors," White said. ER-negative tumors lack receptors that allow estrogen to help cancer cells grow, tend to be more aggressive, and have poorer clinical outcomes. Established breast cancer risk factors such as reproductive history, exogenous hormone use, and lifestyle factors have been more strongly linked with hormone receptor-positive tumors. Scientists know less about what raises the risk of ER-negative breast cancer. "Evidence suggests that hormone receptor–negative tumors might have distinct etiologies, yet their risk factors remain largely unknown," the researchers wrote. Because the strongest associations involved tumors without hormone receptors, the authors suggest PFAS may affect cancer risk through non-hormonal biologic pathways such as changes in gene activity or immune system, though the study did not test those explanations. PFOA and PFOS have largely been phased out since gaining widespread use in the 1950s, but most individuals still have measurable levels in their bodies. Exposure to PFAS is extremely common in the United States, where 97% of people have detectable levels in their blood. PFAS are used to prevent food from sticking to packaging and to make clothing and carpets more stain-resistant. Their carbon-fluorine bonds make the chemicals highly resistant to breaking down, allowing them to remain in the environment for long periods. "Although PFAS are persistent in the environment and in our bodies, exposure to them is still potentially modifiable, meaning people can take steps to reduce their exposure, and these findings could open new avenues for prevention," said first author Che-Jung Chang, PhD, a former research fellow at NIH and current researcher at DLH Corporation. White added that more research is needed, particularly evaluating the risk of breast cancer associated with newer replacement PFAS chemicals. Kennedy Jr. commented: "Women deserve clear answers about how chemicals in their environment may affect their health. This NIH study links two forever chemicals to a higher risk of ER-negative breast cancer and demands further investigation. Under President Trump's leadership, we will pursue the evidence, confront environmental health risks, and give women the information they need to protect their health." The researchers did not establish a causal link between the chemicals and cancer.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (96% supported) Updated 2d ago.

Quick answers

Which PFAS chemicals were linked to aggressive breast cancer in the NIH study?

The study linked perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) to higher rates of ER-negative breast cancer.

How much higher was the rate of ER-negative breast cancer for women with the highest PFAS blood levels?

Women with the highest PFOA levels had a 67% higher rate of ER-negative breast cancer, while those with the highest PFOS levels had a 93% higher rate — nearly twice as high — compared to women with the lowest levels.

What is ER-negative breast cancer and why is it considered more aggressive?

ER-negative breast cancer lacks estrogen receptors, meaning the hormone estrogen does not fuel the tumor's growth. These tumors tend to be more aggressive, have fewer known risk factors, and poorer clinical outcomes than hormone receptor-positive breast cancers.

Coverage (11)

Topics

Related trends

◼ Archived Health

New study links COVID to fewer long-term health problems

About half of adults with long COVID saw sustained symptom improvement within three years of infection, according to a three-year NIH-funded study published in Annals of Internal Medicine.

7 sources 9 articles v 6 3d ago
\n \n \n \n \n \n \n